about
Hovenia dulcis Thunb extract and its ingredient methyl vanillate activate Wnt/β-catenin pathway and increase bone mass in growing or ovariectomized miceDose-dependence of PTH-related peptide-1 on the osteogenic induction of MC3T3-E1 cells in vitro.Altered bone development in a mouse model of peripheral sensory nerve inactivation.Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.Euodia sutchuenensis Dode extract stimulates osteoblast differentiation via Wnt/β-catenin pathway activationBone mechanotransduction may require augmentation in order to strengthen the senescent skeleton.Identification and Characterization of a Synthetic Osteogenic Peptide.Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates.Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone.Effective treatment of a steroid-induced femoral neck fracture nonunion with a once-weekly administration of teriparatide in a rheumatoid patient: a case report.Methyl Gallate Inhibits Osteoclast Formation and Function by Suppressing Akt and Btk-PLCγ2-Ca2+ Signaling and Prevents Lipopolysaccharide-Induced Bone Loss.Effect of osteoporosis medications on fracture healing.Osteocytic signalling pathways as therapeutic targets for bone fragility.MMP9 regulates the cellular response to inflammation after skeletal injury.Alpinia officinarum Stimulates Osteoblast Mineralization and Inhibits Osteoclast Differentiation.Expression of sclerostin scFv and the effect of sclerostin scFv on healing of osteoporotic femur fracture in rats.Protective Mechanisms of Simvastatin in Experimental Periodontal Disease
P2860
Q28538976-EFFF50B9-338B-4357-9498-E1AE332BEFDFQ33627058-87D9636F-E5C1-41DF-BA41-C07994EB359AQ34009564-8FE04D77-FB6E-45CB-BB9B-2700A76A5778Q35017714-96FD8783-C02B-4429-8D7A-28A9FB008E5DQ35152942-187551CA-2D3A-40CB-B83C-FE3B3FA02BE1Q35954422-165EF140-C79F-45E6-8881-FF905FC22AEFQ36236833-A90E053E-2DB3-49A0-A61C-3C52A930FE0DQ37083734-E9519300-9B0A-4F39-9E99-37D9264792BCQ37407566-DAF09ADD-3D09-4FFB-815B-9806F19B9A46Q37470087-D134D97B-1630-4460-B304-48A4B3DB62A1Q37729189-13E2ADC3-2BC6-4F36-8E5B-AA0616123B4CQ38595303-BA27DFB9-2E28-4A45-B3A6-00A5C3507E1CQ38845640-6C804F42-BCC6-48CF-8CB3-37A15EA3794CQ42383995-731D024F-51CD-4620-95A0-4DFDB924183CQ46276831-64B5A063-E96E-4CA7-8E86-2FDFA77D03E7Q53088327-1E1EC728-738C-41F1-892C-4FE85F5FBF8EQ57450694-FE4AFD45-BE4A-47D2-B8AC-DFFCCB8E5CFB
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anabolic agents and bone quality
@ast
Anabolic agents and bone quality
@en
type
label
Anabolic agents and bone quality
@ast
Anabolic agents and bone quality
@en
prefLabel
Anabolic agents and bone quality
@ast
Anabolic agents and bone quality
@en
P2093
P2860
P1476
Anabolic agents and bone quality
@en
P2093
Elise F Morgan
Tarek Sibai
Thomas A Einhorn
P2860
P2888
P304
P356
10.1007/S11999-010-1722-9
P407
P577
2011-08-01T00:00:00Z